Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$346,697
-$1,127,940 QoQ
Shares Held
8,127
-73.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#388
of 712 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $26,089,534 across 7 Drug Manufacturers - General names. SNY ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
868,402 | $20,911,120 | |
| 2 | NVO |
Novo Nordisk A S
|
63,042 | $3,022,233 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,890 | $996,822 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
7,041 | $405,702 | |
| 5 | ABBV |
AbbVie Inc.
|
1,609 | $404,888 | |
| 6 | SNY |
Sanofi
This page
|
8,127 | $346,697 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
130 | $2,072 |
All Filings in SNY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,697 | 8,127 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $1,474,637 | 30,430 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $181,307 | 3,753 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $3,722,745 | 76,726 | Shares | Sole | 2024-08-14 | |
| 2022-12-31 | $977,365 | 20,181 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,741 | 151 | Shares | Sole | 2022-11-09 | |
| 2021-12-31 | $4,345,473 | 86,736 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,454,439 | 71,654 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,098,738 | 77,834 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,787,929 | 36,149 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||